FCH sets screening

August 2013
Jacksboro Gazette-News;8/6/2013, Vol. 134 Issue 10, p3
No abstract available.


Related Articles

  • Flower council shuts UK office.  // Horticulture Week;11/13/2009, p8 

    The article reports that the Flower Council of Holland (FCH) has shut down its office in Great Britain and has laid off four staff for its 600,000 pounds publicity campaign. It notes that the move to close its Salisbury, England office and staff lay offs are part of a wider reorganization of the...

  • Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation. Tomohide Hori; Yasuharu Onishi; Hideya Kamei; Nobuhiko Kurata; Masatoshi Ishigami; Yoji Ishizu; Yasuhiro Ogura // Annals of Gastroenterology;2016, Vol. 29 Issue 4, p454 

    Hepatitis C recurrence continues to present a major challenge in liver transplantation (LT). Approximately 10% of hepatitis C virus (HCV)-positive recipients will develop fibrosing cholestatic hepatitis (FCH) after LT. FCH is clinically characterized as marked jaundice with cholestatic hepatic...

  • Variational Models of Network Formation and Ion Transport: Applications to Perfluorosulfonate Ionomer Membranes. Gavish, Nir; Jones, Jaylan; Xu, Zhengfu; Christlieb, Andrew; Promislow, Keith // Polymers (20734360);Mar2012, Vol. 4 Issue 1, p630 

    We present the functionalized Cahn-Hilliard (FCH) energy, a continuum characterization of interfacial energy whose minimizers describe the network morphology of solvated functionalized polymer membranes. With a small set of parameters the FCH characterizes bilayer, pore-like, and micelle network...

  • Practical Recommendations for Familial Combined Hyperlipidemia Diagnosis and Management: An Update. Gaddi, Antonio V.; F. G. Cicero, Arrigo; Odoo, Fred O.; Poli, Andrea; Paoletti, Rodolfo // Vascular Disease Prevention;Jul2007, Vol. 4 Issue 3, p229 

    Familial Combined Hyperlipidemia (FCH) is a common metabolic disorder characterized by: a) increase in cholesterolemia and/or triglyceridemia in at least two members of the same family, b) intraindividual and intrafamilial variability of the lipid phenotype, and, c) increased risk of premature...

  • ATL>Rapidly progressive fibrosing cholestatic hepatitis-hepatitis C virus in HIV coinfection. Rosenberg, Peter M.; Farrell, James J.; Abraczinskas, Diane R.; Graeme-Cook, Fiona M.; Dienstag, Jules L.; Chung, Raymond T. // American Journal of Gastroenterology;Feb2002, Vol. 97 Issue 2, p478 

    Fibrosing cholestatic hepatitis (FCH) is a severe and progressive form of liver dysfunction seen in organ transplant recipients infected with hepatitis B virus or hepatitis C virus (HCV) and has been attributed to cytopathic liver injury. To date, no case of FCH due to HCV has been reported in...

  • Pulse Wave Velocity in Familial Combined Hyperlipidemia ter Avest, Ewoud; Holewijn, Suzanne; Bredie, Sebastian J.H.; van Tits, Lambertus J.H.; Stalenhoef, Anton F.H.; de Graaf, Jacqueline // American Journal of Hypertension;Mar2007, Vol. 20 Issue 3, p263 

    Background: In the present cross-sectional study we investigated whether familial combined hyperlipidemia (FCH) is associated with an increased arterial wall stiffness, and whether measures of arterial wall stiffness in FCH family members could contribute to cardiovascular risk stratification....

  • MISCELLANEOUS.  // FineScale Modeler;Jan2012, Vol. 31 Issue 1, p19 

    The article previews several products including the Bofors and M42 40millimeter (mm) gun ammunition and accessory set No. AF35189 from AFV Club, the Soviet PAG-14 Airflied plates No. 48231 from Squadron Products and Sophia's Balcony No. FCH020 from Full Circle Hobbies.

  • Spektrum po�adovan�ch vy�etren� nukle�rnej medic�ny pri karcin�me prostaty po registr�cii 18F fluorochol�nu: dvojrocn� sledovanie v nemocnici Tenon. Balogov�, Sona; Huchet, Virginie; Michaud, Laure; Kerrou, Khaldoun; Paycha, Fr�derique; Nataf, Val�rie; Vereb, Marika; Kalisk�, Lucia; Montravers, Fran�oise; Talbot, J.-N. // Nuclear Medicine / Nukle�rn� Medic�na;2012, Vol. 1 Issue 3, p42 

    Introduction: The registration of a new PET radiopharmaceutical by medicines agencies is infrequent and it seemed interesting to follow its consequences on the prescription of alternative nuclear medicine (NM) examinations by the referring physicians. F-18 fluorocholine (FCH) was registered in...

  • Hydrogen technologies and applications: safety. Ruiz, Patricia; Jiménez, Cristina; Llorca, Marta; Vega, Lourdes F. // Advances in Science & Technology;2014, Vol. 93, p124 

    H2TRUST is a Coordination and Support Action integrated by a team of European Fuel Cell and Hydrogen (FCH) industry leaders to foster a smooth and well managed transition to a full scale commercialization of FCH applications in Europe and, to aid the process by which all industry stakeholders...

  • False-negative Bone Scan and Choline PET/CT Study in a Case of Prostate Cancer: The Pitfall of the Small Cell Prostate Carcinoma Variant. Al-Tamimi, Ammad; Tan, Andrew Eik Hock; Kwong, Sidney Yu Wing; Sam, Christopher Cheng Wai; Chong, Angela; Cher Heng Tan // World Journal of Nuclear Medicine;May2012, Vol. 11 Issue 2, p75 

    We present a rare variant of prostate carcinoma. The patient is a 45-year-old male with elevated prostate-specific antigen levels at screening. Magnetic resonance imaging revealed hyperenhancing lesions throughout the axial skeleton. The fluorine-18 fluorocholine (FCH) positron emission...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics